Abstract
Standard treatment for early-stage cervical cancer (Ib2-IIa and IIb with parametrial invasion) is concurrent chemoradiotherapy and/or radical hysterectomy. The efficacy of intra-arterial delivery of neoadjuvant chemotherapy (IANAC) for this cancer remains unclear. We present three cases treated by IANAC for Ib-II stage cervical cancer, with results suggesting that IANAC is an effective treatment. J Clin Gynecol Obstet. 2017;6(2):37-40 doi: https://doi.org/10.14740/jcgo435w
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
